DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) ha anunciado hoy que el Comité de Medicamentos de Uso Humano (CHMP) de la Agencia Europea de Medicamentos (EMA) ha adoptado una opinión positiva recomendando la autorización de comerciali…
Author: Business Wire
ModMed® Surpasses 100 Million Patient Encounters in Eye Care
NEW ORLEANS–(BUSINESS WIRE)–At this year’s AAO Event in New Orleans, healthcare technology leader ModMed is demonstrating the latest innovations from its award winning and widely used ModMed® Ophthalmology software suite that is designed to support p…
Samenvatting: Horizon Therapeutics plc ontvangt positief CHMP-advies voor UPLIZNA® (inebilizumab) als monotherapie voor de behandeling van volwassen patiënten met neuromyelitis Optica Spectrum Disorder (NMOSD)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) heeft vandaag aangekondigd dat het Comité voor geneesmiddelen voor menselijk gebruik (CHMP) van het Europees Geneesmiddelenbureau (EMA) een positief advies heeft uitgebracht waarin het in…
New Real-World Data Show High Rate of Patient Adherence to TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics announces findings of a real-world adherence analysis of TEPEZZA (teprotumumab-trbw) for the treatment of TED at AAO 2021.
Gemini Therapeutics Announces Poster Presentation at AAO 2021
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration (AMD), today announced that Raj Maturi, M…
MingSight Completes a New Round of Financing to Accelerate Clinical Development in Chronic Lymphocytic Leukemia and Diabetic Macular Edema
SAN DIEGO–(BUSINESS WIRE)–MingSight Pharmaceuticals announced today the close of a pre-Series B round of $20M, led by Kaitai Capital. The proceeds will be used for the clinical development of MS-553, a new generation inhibitor of protein kinase C (PK…
Inflammasome Therapeutics’ CEO to Be Featured Speaker at Upcoming Virtual Summit on Inflammasomes
NEWTON, Mass.–(BUSINESS WIRE)– #NRTIs–Inflammasome Therapeutics’ CEO to be Featured Speaker at Virtual Summit on Inflammasomes – to discuss role of inflammasome activation in ophthalmology
Horizon Therapeutics plc erhält positive Stellungnahme des CHMP (Ausschuss für Humanarzneimittel) für UPLIZNA® (Inebilizumab) als Monotherapie zur Behandlung von erwachsenen Patienten mit einer Neuromyelitis Optica Spektrum Disorder (NMOSD)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur (EMA) eine positive Stellungnahme für die Empfehlung der Zulassung von UPLIZNA® (I…
Horizon Therapeutics plc reçoit un avis positif du CMUH pour UPLIZNA® (inébilizumab) en monothérapie pour le traitement des patients adultes atteints de troubles du spectre de la neuromyélite optique (TSNO)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) a annoncéaujourd’hui que le comité des médicaments à usage humain (CMUH) de l’Agence européenne des médicaments (AEM) a émis un avis favorable recommandant l’octroi d’une AMM pour UPLIZNA…
Horizon Therapeutics plc riceve il parere positivo del CHMP (Comitato per i medicinali per uso umano) per UPLIZNA® (inebilizumab) come monoterapia per il trattamento di pazienti adulti affetti da disturbo dello spettro della neuromielite ottica
DUBLINO–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) oggi ha annunciato che il Comitato per i medicinali per uso umano (CHMP) dell’Agenzia europea per i medicinali (EMA) ha rilasciato un parere positivo che raccomanda l’autorizzazione all’…
Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA® (inebilizumab) as a Monotherapy for the Treatment of Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization f…
LENSAR Announces Poster Presentations at the American Academy of Ophthalmology
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that two posters have …
Warby Parker Announces Third Quarter Fiscal Year 2021 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the quarter ended September 30, 2021. “Every day, we strive to design high-…
Global Optical Coherence Tomography Market (2021 to 2029) – by Technology Type, Application Type and Geography – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Coherence Tomography Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” report has been added to ResearchAndMarkets.co…
GenSight Biologics to Present New Clinical Data of LUMEVOQ® and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
EvoqTM Technologies Achieves Breakthrough With Its Smartphone-Based System for Early Detection and Diagnosis of Diseases
LAS VEGAS–(BUSINESS WIRE)–The newly released Evoq Smartphone-Based Electrophysiology System represents a revolutionary, cost-effective alternative to legacy desktop devices. The Evoq system is tailored to meet the needs of MD, OD, PhD, DVM, researche…
NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2021 and provides a business update. “This has been a great year for NovaBay. Avenova r…
BTIG to Host Ophthalmology Day at BTIG on November 30, 2021
NEW YORK–(BUSINESS WIRE)–BTIG announced today that Ophthalmology Day at BTIG will take place on Tuesday, November 30, 2021. The virtual, one-day event will include thematic panel discussions, fireside chats and one-on-one meetings. The event will be …
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that…
Global Iris Recognition Market (2021 to 2025) – Featuring Aware, BioEnable Technologies and Honeywell International Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Iris Recognition Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the iris recognition market and it is poised to grow by $1.33 billion during 2021-2025…